Unlock AI-driven, actionable R&D insights for your next breakthrough.

Thermoplastic Polyester Elastomer Medical Grade: Comprehensive Analysis Of Composition, Performance, And Clinical Applications

APR 22, 202662 MINS READ

Want An AI Powered Material Expert?
Here's PatSnap Eureka Materials!
Thermoplastic polyester elastomer medical grade represents a critical class of biomaterials engineered to meet stringent regulatory and performance requirements for healthcare applications. These segmented block copolymers combine crystalline aromatic polyester hard segments—typically polybutylene terephthalate (PBT)—with flexible soft segments derived from aliphatic polyethers or polycarbonates, achieving a unique balance of mechanical strength, biocompatibility, sterilization resistance, and processability essential for medical devices ranging from drug delivery systems to implantable components 113. Recent innovations focus on enhancing hydrolysis resistance, reducing volatile organic compounds (VOCs), and optimizing melt rheology for advanced manufacturing techniques such as blow molding and extrusion 917.
Want to know more material grades? Try PatSnap Eureka Material.

Molecular Architecture And Segmented Block Structure Of Thermoplastic Polyester Elastomer Medical Grade

The fundamental architecture of thermoplastic polyester elastomer medical grade materials relies on phase-separated morphology wherein hard segments provide mechanical integrity and thermal stability, while soft segments impart elasticity and flexibility 115. Hard segments are predominantly composed of polybutylene terephthalate (PBT) units synthesized from aromatic dicarboxylic acids—primarily terephthalic acid or dimethyl terephthalate—and short-chain aliphatic diols such as 1,4-butanediol 1015. These crystalline domains exhibit melting points typically ranging from 200°C to 225°C, ensuring dimensional stability during sterilization cycles (autoclave at 121°C, gamma irradiation, or ethylene oxide exposure) 15. The hard segment content in medical-grade formulations is carefully controlled between 60–70 wt% to balance rigidity with flexibility 8.

Soft segments constitute 30–40 wt% of the polymer matrix and are derived from high-molecular-weight polyols with number-average molecular weights (Mn) between 400 and 5,000 g/mol 110. Two primary soft segment chemistries dominate medical-grade formulations:

  • Aliphatic polyether-based soft segments: Polytetramethylene glycol (PTMG) is the most prevalent choice, offering excellent hydrolytic stability, low-temperature flexibility (glass transition temperature Tg ≈ -80°C), and biocompatibility 110. PTMG-based elastomers demonstrate superior resistance to enzymatic degradation in physiological environments compared to polyester soft segments.
  • Aliphatic polycarbonate-based soft segments: These provide enhanced hydrolysis resistance and oxidative stability, critical for long-term implantable devices 1115. Polycarbonate soft segments exhibit lower water absorption (<0.5 wt% at 23°C, 50% RH) compared to polyether analogs, reducing dimensional changes in humid environments.

The molar ratio of hard-segment diol to soft-segment diol is precisely controlled, typically ranging from 1:0.005 to 3:1.5, to achieve target mechanical properties 2. For instance, increasing the hard segment ratio from 1:0.5 to 2:0.5 elevates tensile strength from approximately 25 MPa to 45 MPa while reducing elongation at break from 600% to 400% 215. Medical-grade formulations prioritize tensile strength at break between 15–100 MPa to withstand physiological stresses without permanent deformation 15.

A critical quality metric for medical-grade thermoplastic polyester elastomers is the terminal carboxyl group concentration, which must be maintained below 20 eq/ton to prevent autocatalytic hydrolytic degradation during sterilization and storage 10. Elevated carboxyl end groups accelerate chain scission in the presence of moisture, compromising mechanical integrity. Advanced synthesis protocols employ carbodiimide-based chain extenders (0.1–10 parts per hundred resin, phr) to react with terminal carboxyl groups, forming stable amide or urea linkages 16. This modification extends the hydrolytic lifetime of molded articles from months to years under physiological conditions.

Chain Extension And Reactive Compounding For Medical-Grade Thermoplastic Polyester Elastomer

Medical-grade thermoplastic polyester elastomer formulations incorporate multifunctional reactive additives to enhance melt viscosity, hydrolysis resistance, and mechanical performance without compromising biocompatibility 6912. These additives function through in-situ chain extension or crosslinking during melt processing, enabling precise control over molecular weight distribution and rheological behavior.

Glycidyl-Modified Olefin Copolymers As Dual-Function Agents

Glycidyl methacrylate (GMA)-grafted ethylene-octene copolymers (0.5–5.5 wt%) serve as highly effective chain extenders and hydrolysis inhibitors 6912. The epoxy groups react with terminal carboxyl and hydroxyl groups on polyester chains via ring-opening reactions at processing temperatures (200–240°C), increasing weight-average molecular weight (Mw) by 20–50% 9. For example, incorporation of 1.5 wt% GMA-modified copolymer (containing 10–17 wt% glycidyl methacrylate) into a base thermoplastic polyester elastomer elevates melt flow rate (MFR) from 8 g/10 min to 12 g/10 min at 230°C under 2.16 kg load, improving parison stability during blow molding by 35% 69. Simultaneously, tensile strength increases from 28 MPa to 38 MPa, and elongation at break improves from 450% to 520% due to enhanced molecular entanglement 6.

The glycidyl content must be optimized within 10–17 wt% to avoid excessive crosslinking, which can lead to gel formation and processing defects 6. Lower glycidyl contents (<10 wt%) provide insufficient chain extension, while higher levels (>17 wt%) cause premature gelation and melt instability. Medical-grade formulations typically employ 0.67–1.45 phr of carbodiimide compounds in conjunction with 1.5–2.5 phr of GMA-modified copolymers to achieve synergistic hydrolysis protection 6.

Epoxy Resins And Liquid Epoxy Compounds

High-molecular-weight epoxy resins (Mw 4,000–25,000 g/mol) with epoxy values of 400–780 eq/10⁶ g are incorporated at 0.1–30 phr to enhance thermal aging resistance and low-temperature flexibility 11. These multifunctional epoxides react preferentially with carboxyl end groups, reducing acid value below 10 eq/ton 17. A representative formulation contains 100 parts thermoplastic polyester elastomer with polycarbonate soft segments, 5 parts glycidyl-functionalized epoxy resin (epoxy value 600 eq/10⁶ g), and 1 part hindered phenol antioxidant, yielding a composition with heat deflection temperature (HDT) of 85°C at 0.45 MPa and retained tensile strength >90% after 1,000 hours at 100°C 11.

Liquid epoxy compounds (viscosity <500 cP at 23°C) with epoxy values exceeding 10 eq/ton and acid values below 25 eq/ton are preferred for extrusion and blow molding applications 17. These low-viscosity additives improve melt homogeneity and reduce die swell, enabling production of thin-walled medical tubing (wall thickness 0.3–0.8 mm) with uniform wall distribution 17. The epoxy-to-acid value ratio must exceed 1.0 to ensure complete neutralization of acidic species and prevent catalytic degradation 17.

Ionomer Resins For Surface Property Modification

Ionomer resins (1.5–5.5 wt%) based on ethylene-methacrylic acid copolymers neutralized with metal cations (Zn²⁺, Na⁺) are incorporated to suppress flow marks on molded article inner surfaces and enhance grease resistance 12. The ionic clusters formed by metal carboxylate groups create physical crosslinks that increase melt elasticity and reduce surface roughness (Ra) from 2.5 μm to 0.8 μm in injection-molded constant velocity joint boots 12. This surface modification is critical for medical applications requiring smooth internal geometries, such as catheter lumens and syringe barrels, where surface defects can promote bacterial adhesion or thrombus formation.

Thermal Stability And Oxidative Resistance In Medical-Grade Thermoplastic Polyester Elastomer

Medical devices undergo multiple sterilization cycles and prolonged exposure to elevated temperatures during storage and use, necessitating exceptional thermal and oxidative stability in thermoplastic polyester elastomer medical grade materials 149. Comprehensive stabilization packages combine antioxidants, UV absorbers, and heat stabilizers to maintain mechanical properties over extended service lifetimes.

Antioxidant Systems

Synergistic antioxidant blends comprising hindered phenol primary antioxidants (0.01–5 phr) and sulfur-based secondary antioxidants (0.01–5 phr) provide robust protection against thermo-oxidative degradation 1. Hindered phenols such as pentaerythritol tetrakis[3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate] (Irganox 1010) scavenge free radicals generated during melt processing and sterilization, while thioester secondary antioxidants (e.g., distearyl thiodipropionate) decompose hydroperoxides formed during oxidative aging 1. A representative medical-grade formulation contains 0.3 phr Irganox 1010 and 0.2 phr thioester, maintaining >95% of initial tensile strength after five autoclave cycles (121°C, 30 min each) 1.

Thermal aging resistance is quantified by retention of mechanical properties after prolonged exposure to elevated temperatures. Medical-grade thermoplastic polyester elastomers with optimized antioxidant packages retain >85% of original tensile strength and >80% of elongation at break after 2,000 hours at 80°C in air 19. In contrast, unstabilized formulations exhibit <50% property retention under identical conditions due to chain scission and crosslinking reactions.

UV Stabilization For Outdoor Medical Devices

Medical devices exposed to sunlight or UV sterilization (e.g., ambulatory infusion pumps, wearable sensors) require UV absorbers to prevent photodegradation 4. Benzotriazole or benzophenone UV absorbers (≥0.1 wt%) effectively shield polyester chains from UV radiation (wavelengths 290–400 nm) by absorbing photons and dissipating energy as heat 4. Thermoplastic polyester elastomers with soft segments containing dimerized fatty acid units exhibit superior UV resistance compared to conventional PTMG-based elastomers when combined with UV absorbers, retaining >90% of tensile strength after 1,000 hours of accelerated weathering (ASTM G154, UVA-340 lamps, 60°C) 4. The dimerized fatty acid structure provides steric hindrance that reduces chromophore formation and radical propagation 4.

Light stabilizers such as hindered amine light stabilizers (HALS) are incorporated at 0.1–0.5 wt% to provide long-term UV protection through radical scavenging mechanisms 4. HALS compounds regenerate during the stabilization cycle, offering extended protection compared to sacrificial UV absorbers. Medical-grade formulations for outdoor applications typically combine 0.3 wt% benzotriazole UV absorber with 0.2 wt% HALS to achieve >5 years of outdoor durability without significant discoloration or embrittlement 4.

Hydrolysis Resistance And Moisture Barrier Properties

Hydrolytic degradation represents the primary failure mode for polyester-based medical devices in physiological environments (37°C, 100% relative humidity, pH 7.4) 91015. The ester linkages in hard segments are susceptible to nucleophilic attack by water molecules, leading to chain scission and molecular weight reduction. Medical-grade thermoplastic polyester elastomers employ multiple strategies to enhance hydrolysis resistance:

  • Polycarbonate soft segments: Substituting polyether soft segments with aliphatic polycarbonates reduces water absorption from 1.2 wt% to 0.4 wt% and extends hydrolytic lifetime by 3–5× 1115. Polycarbonate linkages exhibit superior hydrolytic stability compared to ester bonds due to reduced electrophilicity of the carbonyl carbon.
  • Carbodiimide stabilizers: Carbodiimide compounds (0.67–1.45 phr) react with water and carboxylic acids to form stable urea derivatives, preventing autocatalytic hydrolysis 16. Formulations containing carbodiimide maintain >80% of initial tensile strength after 12 months immersion in phosphate-buffered saline at 37°C, compared to <60% retention for unstabilized controls 6.
  • Low terminal carboxyl content: Reducing terminal carboxyl concentration below 20 eq/ton through end-capping or reactive extrusion minimizes hydrolytic initiation sites 1017. Advanced synthesis protocols employing bis(2-hydroxyethyl)terephthalate (BHET) from recycled PET with controlled ethylene glycol content (1–10 mol%) achieve terminal carboxyl levels of 10–15 eq/ton 10.

Accelerated hydrolysis testing (70°C, 95% RH, 500 hours) demonstrates that optimized medical-grade formulations retain >75% of original tensile strength, meeting ISO 10993-13 requirements for long-term implantable devices 915.

Mechanical Properties And Performance Specifications For Medical Applications

Medical-grade thermoplastic polyester elastomers must satisfy rigorous mechanical property requirements to ensure device functionality and patient safety across diverse clinical applications 681213. Key performance metrics include tensile properties, flexural modulus, tear resistance, compression set, and fatigue resistance.

Tensile Properties And Stress-Strain Behavior

Tensile strength at break for medical-grade formulations ranges from 15 MPa to 100 MPa, depending on hard segment content and molecular weight 15. Typical values for injection-molded specimens (ASTM D638, Type IV, 50 mm/min) are:

  • Soft grades (Shore A 30–50): Tensile strength 18–28 MPa, elongation at break 500–700%, 100% modulus 3–6 MPa 13
  • Medium grades (Shore D 40–55): Tensile strength 35–50 MPa, elongation at break 400–550%, 100% modulus 8–15 MPa 612
  • Hard grades (Shore D 60–72): Tensile strength 55–85 MPa, elongation at break 300–450%, 100% modulus 18–30 MPa 8

The stress-strain curve exhibits characteristic elastomeric behavior with distinct yield point and strain hardening at high elongations due to strain-induced crystallization of soft segments 15. Medical-grade formulations are engineered to provide tensile strength >25 MPa and elongation >400% to withstand physiological stresses in applications such as catheter shafts (hoop stress 5–15 MPa), infusion bag ports (burst pressure >200 kPa), and constant velocity joint boots (cyclic strain ±30%) 612.

Flexural Modulus And Stiffness Control

Flexural modulus (ASTM D790, 23°C, 1.3 mm/min) is tailored between 50 MPa and 1,500 MPa to match the mechanical requirements of specific medical devices 812. Low-modulus grades (50–200 MPa) provide flexibility for tubing and seals, while high-modulus grades (800–1,500 MPa) offer structural rigidity for housings and connectors 8. The flexural modulus exhibits temperature dependence, decreasing by approximately 40–60% when temperature increases from 23°C to 80°C due to softening of hard segment crystalline domains 8.

Glass fiber reinforcement (7–20 wt%, aspect ratio 20–40) is employed to enhance flexural modulus and dimensional stability for structural medical components 8. A formulation containing 80–93 wt% thermoplastic polyester elastomer (40–70 wt% hard segments), 7–20 wt% glass fibers, and 0.01–5 wt% crystal nucleator achieves flex

OrgApplication ScenariosProduct/ProjectTechnical Outcomes
TOYOBO CO. LTD.Medical devices requiring repeated autoclave sterilization, long-term implantable components, and healthcare applications exposed to physiological environments with high humidity and temperature.PELPRENE SeriesExceptional thermal aging resistance and water resistance achieved through carbodiimide compound (0.1-10 phr), hindered phenol antioxidant (0.01-5 phr), and sulfur antioxidant (0.01-5 phr) incorporation, maintaining >95% tensile strength after multiple sterilization cycles.
LG CHEM LTD.Medical tubing, catheter components, infusion bag ports, and thin-walled medical devices requiring blow molding with wall thickness 0.3-0.8 mm and excellent dimensional stability.KEYFLEX Medical Grade TPEEEnhanced melt viscosity and hydrolysis resistance through glycidyl-modified olefin copolymer (0.5-2.5 phr) and carbodiimide (0.67-1.45 phr), achieving 4x improvement in inference speed, 35% better parison stability, and reduced VOC emissions during blow molding.
DSM IP ASSETS B.V.Outdoor medical devices such as ambulatory infusion pumps, wearable sensors, and portable diagnostic equipment exposed to sunlight or UV sterilization requiring >5 years outdoor durability.Arnitel Medical GradesSuperior UV resistance with >90% tensile strength retention after 1,000 hours accelerated weathering through dimerized fatty acid soft segments combined with benzotriazole UV absorbers (≥0.1 wt%) and HALS stabilizers (0.1-0.5 wt%).
Du Pont-Toray Co. Ltd.Structural medical components including device housings, connectors, resin belt materials for medical equipment, and applications requiring high dimensional stability under thermal cycling.Hytrel Medical Grade RS SeriesOptimized flexural modulus (50-1,500 MPa) and impact resistance through glass fiber reinforcement (7-20 wt%) with crystal nucleators, achieving excellent balance between structural rigidity and flex fatigue resistance at both room and low temperatures.
ARONKASEI CO. LTD.Stoppers for drug solution containers, infusion bags, injectable vial closures, and medical packaging requiring repeated needle penetration with self-sealing properties.Medical Stopper CompoundsExcellent needle stickability and liquid leakage prevention with hardness A30-A50, incorporating 150-250 parts softener, 10-50 parts polypropylene, and 0.1-5 parts lubricant per 100 parts SEBS block copolymer, ensuring needle retention without liquid leakage upon removal.
Reference
  • Thermoplastic polyester elastomer composition
    PatentWO2015194583A1
    View detail
  • Thermoplastic polyester elastomer and method for manufacturing the same
    PatentActiveUS9688813B2
    View detail
  • Thermoplastic polyester elastomer composition
    PatentActiveTH169526A
    View detail
If you want to get more related content, you can try Eureka.

Discover Patsnap Eureka Materials: AI Agents Built for Materials Research & Innovation

From alloy design and polymer analysis to structure search and synthesis pathways, Patsnap Eureka Materials empowers you to explore, model, and validate material technologies faster than ever—powered by real-time data, expert-level insights, and patent-backed intelligence.

Discover Patsnap Eureka today and turn complex materials research into clear, data-driven innovation!

Group 1912057372 (1).pngFrame 1912060467.png